Android app on Google Play

H.C. Wainwright Starts Cell Therapeutics (CTIC) at Buy

November 4, 2013 7:34 AM EST Send to a Friend
Get Alerts CTIC Hot Sheet
Price: $2.68 +0.75%

Rating Summary:
    8 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 24 | New: 21
Trade CTIC Now!
Join SI Premium – FREE
H.C. Wainwright initiates coverage on Cell Therapeutics (NASDAQ: CTIC) with a Buy. PT $4.00.

For an analyst ratings summary and ratings history on Cell Therapeutics click here. For more ratings news on Cell Therapeutics click here.

Shares of Cell Therapeutics closed at $1.63 yesterday.




You May Also Be Interested In


Related Categories

New Coverage

Add Your Comment